Skip to main content
. 2022 Apr 11;14(8):1930. doi: 10.3390/cancers14081930

Figure 8.

Figure 8

Summary of lung metastases results shows need for combination therapy. Schematic of survival results, with CD47-SIRPα disruption and tumor opsonization extending survival in combination, but not separately based on statistical significance. Each point is representative of median (square: 50% survival) or 80th percentile (triangle: 20% survival) survival time for the indicated group and is normalized to the survival of the untreated.